Sartorius Stedim Biotech
Key Figures for the First Half and Second Quarter of 2020
| in millions of € unless otherwise specified | ||||
| 6 months 2020 | 6 months 2019 | Change in % | Change in % cc1 | |
| Order Intake and Sales Revenue | ||||
| Order intake | 1,048.7 | 778.1 | 34.8 | 34.1 |
| Sales revenue | 869.1 | 709.3 | 22.5 | 22.0 |
| - EMEA2 | 340.3 | 288.0 | 18.2 | 18.3 |
| - Americas2 | 312.6 | 251.8 | 24.1 | 21.9 |
| - Asia | Pacific2 | 216.2 | 169.6 | 27.5 | 28.5 |
| Results | ||||
| EBITDA3 | 262.3 | 205.3 | 27.8 | |
| EBITDA margin3 in % | 30.2 | 28.9 | ||
| Net profit4 | 167.4 | 131.1 | 27.7 | |
| Earnings per share4 in € | 1.82 | 1.42 | 27.7 | |
| June 30, 2020 | Dec. 31, 2019 | |||
| Balance Sheet | Financials | ||||
| Balance sheet total | 2,224.1 | 1,845.4 | ||
| Equity | 1,287.9 | 1,188.9 | ||
| Equity ratio in % | 57.9 | 64.4 | ||
| Net debt | 243.2 | 110.4 | ||
| Ratio of net debt to underlying EBITDA | 0.5 | 0.3 | ||
| in millions of € unless otherwise specified | ||||
| 2nd Quarter 20205 | 2nd Quarter 20195 | Change in % | Change in % cc1 | |
| Order Intake and Sales Revenue | ||||
| Order intake | 514.0 | 396.8 | 29.5 | 29.2 |
| Sales revenue | 447.0 | 366.4 | 22.0 | 21.7 |
| - EMEA2 | 172.7 | 147.3 | 17.2 | |
| - Americas2 | 159.9 | 127.1 | 25.8 | |
| - Asia | Pacific2 | 114.4 | 92.0 | 24.4 | |
| Results | ||||
| EBITDA3 | 135.6 | 107.2 | 26.5 | |
| EBITDA margin3 in % | 30.3 | 29.3 | ||
| Net profit4 | 87.2 | 68.5 | 27.1 | |
| Earnings per share4 in € | 0.95 | 0.74 | 27.1 | |
1 cc = in constant currencies
2 According to customer location
3 Underlying EBITDA = earnings before interest, taxes, depreciation and amortization, and adjusted for extraordinary items
4 Underlying net profit = net profit after non-controlling interest; adjusted for extraordinary items, amortization and based on a normalized financial result and tax rate
5 Figures are not audited nor reviewed